Literature DB >> 25403333

Root and shoot parts of strawberry: factories for production of functional human pro-insulin.

Ashkan Tavizi1, Mokhtar Jalali Javaran, Ahmad Moieni, Manijeh Mohammadi-Dehcheshmeh, Mehdi Mohebodini, Esmaeil Ebrahimie.   

Abstract

Diabetes, a disease caused by excessive blood sugar, is caused by the lack of insulin. For commercial production, insulin is made in bacteria or yeast by protein recombinant technology. The focus of this research is evaluating another resource and producing of recombinant insulin protein in as strawberry as this plant has high potential in production of pharmaceutical proteins. Strawberry is a suitable bioreactor for production of recombinant proteins especially edible vaccines. In this research, human pro-insulin gene was cloned in pCAMBIA1304 vector under CaMV35S promoter and NOS terminator. Agrobacterium tumefaciens LBA4404, AGL1, EHA105, EHA101, C58, C58 (pGV2260) and C58 (pGV3101) strains were used for transformation of pro-insulin gene into strawberry cv. Camarosa, Selva, Sarian Hybrid, Pajaro, Paros, Gaviota, Alpine. Additionally, Agrobacterium rhizogenes K599, R1000, A4 and MSU440 strains were utilized for gene transformation into hairy roots. PCR analysis indicated the presence of transformed human pro-insulin gene in the strawberry and hairy roots. Also, its transcription was confirmed using RT-PCR. Furthermore, the analysis of plants, fruits and hairy roots at the level of proteins using dot blot, ELISA, SDS-PAGE and ECL tests re-confirmed the expression of this protein in the transgenic plants as well as hairy roots. Protein purification of human pro-insulin from transgenic tissues was performed using affinity chromatography. Finally, the bioassay of recombinant pro-insulin was performed. The analysis of second generations of transgenic plants (T1) at DNA and protein levels was also performed as a complementary experiment. This study opens a new avenue in molecular farming of human pro-insulin through its mass production in roots and shoots of strawberry.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25403333     DOI: 10.1007/s11033-014-3837-7

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  8 in total

Review 1.  Expression of insulin in yeast: the importance of molecular adaptation for secretion and conversion.

Authors:  T Kjeldsen; P Balschmidt; I Diers; M Hach; N C Kaarsholm; S Ludvigsen
Journal:  Biotechnol Genet Eng Rev       Date:  2001

Review 2.  Challenges for the oral delivery of macromolecules.

Authors:  Michael Goldberg; Isabel Gomez-Orellana
Journal:  Nat Rev Drug Discov       Date:  2003-04       Impact factor: 84.694

3.  Increased production of human proinsulin in the periplasmic space of Escherichia coli by fusion to DsbA.

Authors:  J Winter; P Neubauer; R Glockshuber; R Rudolph
Journal:  J Biotechnol       Date:  2001-11-30       Impact factor: 3.307

Review 4.  Concept, strategies, and feasibility of noninvasive insulin delivery.

Authors:  William T Cefalu
Journal:  Diabetes Care       Date:  2004-01       Impact factor: 19.112

5.  Transgenic expression and recovery of biologically active recombinant human insulin from Arabidopsis thaliana seeds.

Authors:  Cory L Nykiforuk; Joseph G Boothe; Elizabeth W Murray; Richard G Keon; H Joseph Goren; Nancy A Markley; Maurice M Moloney
Journal:  Plant Biotechnol J       Date:  2006-01       Impact factor: 9.803

6.  Chloroplast-derived vaccine antigens confer dual immunity against cholera and malaria by oral or injectable delivery.

Authors:  Abdoreza Davoodi-Semiromi; Melissa Schreiber; Samson Nalapalli; Dheeraj Verma; Nameirakpam D Singh; Robert K Banks; Debopam Chakrabarti; Henry Daniell
Journal:  Plant Biotechnol J       Date:  2009-12-28       Impact factor: 9.803

7.  A plant-based cholera toxin B subunit-insulin fusion protein protects against the development of autoimmune diabetes.

Authors:  T Arakawa; J Yu; D K Chong; J Hough; P C Engen; W H Langridge
Journal:  Nat Biotechnol       Date:  1998-10       Impact factor: 54.908

Review 8.  Medical molecular farming: production of antibodies, biopharmaceuticals and edible vaccines in plants.

Authors:  H Daniell; S J Streatfield; K Wycoff
Journal:  Trends Plant Sci       Date:  2001-05       Impact factor: 18.313

  8 in total
  2 in total

Review 1.  Current advances and future prospects in production of recombinant insulin and other proteins to treat diabetes mellitus.

Authors:  Sapna Bhoria; Jyoti Yadav; Honey Yadav; Darshna Chaudhary; Ranjana Jaiwal; Pawan K Jaiwal
Journal:  Biotechnol Lett       Date:  2022-04-17       Impact factor: 2.461

Review 2.  Compendium on Food Crop Plants as a Platform for Pharmaceutical Protein Production.

Authors:  Aneta Gerszberg; Katarzyna Hnatuszko-Konka
Journal:  Int J Mol Sci       Date:  2022-03-17       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.